Bullzeye FinancialCyient Ltd.
NSE: CYIENT · Information Technology
Strong technical recovery and Q1 profit growth lack fundamental validation; low volume and missing valuation data prevent conviction…
Q1 FY27 showed EBIT +9.5% QoQ and PBT +80.1% YoY with stock recovering 45% from lows, outperforming NIFTY by 4.5% over 12 months and holding above 200-day EMA with RSI at 61.
Rally is occurring on only 49% of average volume with no P/E, growth rates, or margin data to justify the 38% six-month surge, and the stock underperformed NIFTY by 4.5% over 12 months before this bounce.
Free: 5 Forecasts and 5 Debates a month. Log in with your mobile number.
-
Neutral 28 Sep 2026 → now Scores 28 Oct 2026₹1,082.30 → ₹1,082.30 0.0%
Every verdict and forecast here is dated and scored when it matures — right or wrong. The first scored results publish a month after launch.
How we score →